Evdi Injection, Solution, Concentrate
Product Images NDC 60505-6423

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Evdi (NDC 60505-6423). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Apotex Corp., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ctn-lbl.jpg (Ctn Lbl)

Label for EVDI (trabectedin) Injection, 1 mg/20 mL (0.05 mg/mL) concentrate for intravenous infusion after dilution. The label displays warnings about the drug's hazardous nature and states it is a single-dose vial with instructions to discard unused portions. It includes manufacturer information for Latina Pharma S.P.A., Italy, and Apotex Corp., Weston, FL, along with storage instructions and inactive ingredients.*

FDA Label Image

Figure1.jpg (Figure1)

A survival curve chart comparing the percentage of subjects alive and progression-free over time in months for two treatments: Dacarbazine and Trabectedin. The chart includes censored data points for both treatments, marked with symbols. Also displayed below the x-axis is the number of subjects at risk at different time intervals for each treatment group.*

FDA Label Image

Structure.jpg (Structure)

Chemical structure of Trabectedin, the active ingredient in EVDI 0.05 mg/mL injection solution concentrate by Apotex Corp. The diagram depicts the molecular arrangement of atoms and bonds characteristic of Trabectedin.*

FDA Label Image

Vial-lbl.jpg (Vial Lbl)

EVDI (trabectedin) Injection label for intravenous infusion, showing strength 1 mg/20 mL (0.05 mg/mL). The label includes NDC 60505-6423-0, warnings about hazardous drug handling, storage instructions at 2°C to 8°C, and manufacturing information by Latina Pharma S.P.A. for Apotex Corp. in Weston, Florida. The label specifies a single-dose vial and requires discarding unused portions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.